Form 4 for CNMD CONMED Corp
Accepted 2021-11-04 00:00:00 ET · period of report 2021-11-02 · accession 0001127602-21-028376 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-04 | 2021-11-02 | CNMD | KENNEDY JOHN JED | Group EVP | S - Sale+OE | $147.64 | -9,462 | 7,375 | -56% | -$1.40M |
| DM | 2021-11-04 | 2021-11-02 | CNMD | KENNEDY JOHN JED | Group EVP | M - OptEx | $68.67 | +9,462 | 8,237 | New | +$649.8K |
| DM | 2021-11-04 | 2021-11-02 | CNMD | KENNEDY JOHN JED | Group EVP | M - OptEx | $0.00 | -9,462 | 10.8K | -47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-02 | S | D | 1,700 | $148.60 | 7,375 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.10 to $148.82. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 2 | Common | Common Stock | 2021-11-02 | M | A | 1,700 | $97.69 | 9,075 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-02 | S | D | 872 | $148.31 | 7,375 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.02 to $148.59. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 4 | Common | Common Stock | 2021-11-02 | S | D | 928 | $147.51 | 8,247 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.94 to $147.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 5 | Common | Common Stock | 2021-11-02 | M | A | 1,800 | $78.76 | 9,175 | D | — | — | |
| 6 | Common | Common Stock | 2021-11-02 | S | D | 3,278 | $147.57 | 7,375 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.36 to $147.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 7 | Common | Common Stock | 2021-11-02 | S | D | 1,822 | $147.06 | 10,653 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.34 to $147.31. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 8 | Common | Common Stock | 2021-11-02 | M | A | 5,100 | $59.96 | 12,475 | D | — | — | |
| 9 | Common | Common Stock | 2021-11-02 | S | D | 862 | $146.67 | 7,375 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.24 to $147.01. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 10 | Common | Common Stock | 2021-11-02 | M | A | 862 | $41.93 | 8,237 | D | — | — | |
| 11 | Derivative | Options To Purchase Common Stock | 2021-11-02 | M | D | 1,700 | $0.00 | 7,600 | D | $97.69 · — to 2030-03-02 | 1,700 Common Stock | (F8) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 12 | Derivative | Options To Purchase Common Stock | 2021-11-02 | M | D | 1,800 | $0.00 | 5,700 | D | $78.76 · — to 2029-03-01 | 1,800 Common Stock | (F8) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 13 | Derivative | Options To Purchase Common Stock | 2021-11-02 | M | D | 862 | $0.00 | 5,000 | D | $41.93 · — to 2027-03-01 | 862 Common Stock | (F7) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| 14 | Derivative | Options To Purchase Common Stock | 2021-11-02 | M | D | 5,100 | $0.00 | 10,800 | D | $59.96 · — to 2028-03-01 | 5,100 Common Stock | (F7) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |